Next Article in Journal
Bioactive Molecules from the Innate Immunity of Ascidians and Innovative Methods of Drug Discovery: A Computational Approach Based on Artificial Intelligence
Next Article in Special Issue
Metabolomics-Guided Discovery of New Dimeric Xanthones from Co-Cultures of Mangrove Endophytic Fungi Phomopsis asparagi DHS-48 and Phomopsis sp. DHS-11
Previous Article in Journal
Karenia brevis Extract Induces Cellular Entry through Distinct Mechanisms in Phagocytic RAW 264.7 Macrophages versus Non-Phagocytic Vero Cells
Previous Article in Special Issue
Cytosporones with Anti-Inflammatory Activities from the Mangrove Endophytic Fungus Phomopsis sp. QYM-13
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 22
Issue 1
10.3390/md22010005
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus Aspergillus chevalieri against Pancreatic Ductal Adenocarcinoma

by
Dina H. El-Kashef
1,2,
Deborah D. Obidake
1,
Katja Schiedlauske
1,
Alina Deipenbrock
1,
Sebastian Scharf
3,
Hao Wang
4,
Daniela Naumann
5,
Daniel Friedrich
5,
Simone Miljanovic
1,
Takin Haj Hassani Sohi
6,
Christoph Janiak
6,
Klaus Pfeffer
3 and
Nicole Teusch
1,*
1
Institute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
2
Department of Pharmacognosy, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt
3
Institute of Medical Microbiology and Hospital Hygiene, Medical Faculty, Heinrich Heine University, 40225 Düsseldorf, Germany
4
Hainan Key Laboratory for Research and Development of Natural Products from Li Folk Medicine, Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agricultural Sciences, Haikou 571101, China
5
Department of Chemistry and Biochemistry, University of Cologne, 50939 Cologne, Germany
6
Institute of Inorganic Chemistry and Structural Chemistry, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany
*
Author to whom correspondence should be addressed.
Mar. Drugs 2024, 22(1), 5; https://doi.org/10.3390/md22010005
Submission received: 30 November 2023 / Revised: 14 December 2023 / Accepted: 17 December 2023 / Published: 20 December 2023
(This article belongs to the Special Issue A Theme Issue Honoring Professor Peter Proksch's 70th Birthday: Bioactive Compounds from the Ocean)
Browse Figures
Versions Notes

Abstract

:
A new prenylated indole diketopiperazine alkaloid, rubrumline P (1), was isolated along with six more analogues and characterized from the fermentation culture of a marine sediment-derived fungus, Aspergillus chevalieri, collected at a depth of 15 m near the lighthouse in Dahab, Red Sea, Egypt. In the current study, a bioassay-guided fractionation allowed for the identification of an active fraction displaying significant cytotoxic activity against the human pancreatic adenocarcinoma cell line PANC-1 from the EtOAc extract of the investigated fungus compared to the standard paclitaxel. The structures of the isolated compounds from the active fraction were established using 1D/2D NMR spectroscopy and mass spectrometry, together with comparisons with the literature. The absolute configuration of the obtained indole diketopiperazines was established based on single-crystal X-ray diffraction analyses of rubrumline I (2) and comparisons of optical rotations and NMR data, as well as on biogenetic considerations. Genome sequencing indicated the formation of prenyltransferases, which was subsequently confirmed by the isolation of mono-, di-, tri-, and tetraprenylated compounds. Compounds rubrumline P (1) and neoechinulin D (4) confirmed preferential cytotoxic activity against PANC-1 cancer cells with IC50 values of 25.8 and 23.4 µM, respectively. Although the underlying mechanism-of-action remains elusive in this study, cell cycle analysis indicated a slight increase in the sub-G1 peak after treatment with compounds 1 and 4.

1. Introduction

Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic neoplasm, is considered the fourth leading cause of cancer-related mortality worldwide due to its high aggressiveness and malignancy with a poor survival rate [1,2]. Despite breakthroughs in diagnostic tools, surgical treatments, and chemotherapy, the overall survival rates of PDAC remain low, and the only available therapies are classical chemotherapeutics with an unselective cytotoxic profile. Consequently, there is an immense need to find new drugs or drug leads for curing this disease [2,3]. Many natural products have been reported to exert anticancer effects against pancreatic cancer [3,4,5]. As part of our ongoing search for discovering novel potential drug candidates for use against PDAC that originate from a natural source [6], a bioassay-guided isolation of secondary metabolites was conducted on a marine sediment-derived fungus, Aspergillus chevalieri, collected from the Red Sea at a depth of 15 m close to the lighthouse of Dahab, Egypt. Accordingly, seven prenylated indole diketopiperazine alkaloids, including a rare tetraprenylated derivative that has been reported only once before, were isolated from the bio-active fraction, identified, and further pharmacologically characterized [7,8]. Indole diketopiperazine alkaloids (DKPs) represent a group of secondary metabolites broadly distributed in filamentous fungi, especially in the genera Aspergillus and Penicillium [9]. Biosynthetically, in fungi, the core cyclic dipeptide nucleus of DKPs is mostly originated from the condensation of two tryptophan amino acids or one tryptophan molecule and another amino acid, assembled by non-ribosomal peptide synthetases (NRPSs) [8,10]. Different putative tailoring enzymes contribute to the structural diversity of DKP scaffolds, including oxidoreductases, hydrolases, methyl transferases, prenyltransferases, and ligases [11,12]. Prenylated indole diketopiperazines are constituted of an indole diketopiperazine backbone and isoprenoid moieties, in which prenylation is catalyzed by prenyltransferases acting as tailoring enzymes [7,8,13]. The subsequent prenylation cascade of echinulin and neoechinulin series of alkaloids in Aspergillus ruber has been demonstrated to be mediated via two prenyltransferases, EchPT1 and EchPT2. These two enzymes are involved in the prenylation and reverse prenylation cascades taking place at different positions of the indole DKP core structure of echinulin and neoechinulin congeners, resulting in the formation of mono-, di-, tri-, and tetraprenylated derivatives [7,8]. Indole DKPs are not only characterized by the diversities in their chemical structures but are also reported to exhibit significant biological activities, such as anti-inflammatory, anticancer, antiviral, anti-neurogenerative, and antioxidant activities [9,14]. Various indole DKPs have been evaluated for their anticancer activities against several cancer lines such as HL-60, P388, BEL-7402, A-549, PC12, and HeLa cells via induction of apoptosis and/inhibition of cell proliferation [14,15,16,17,18]. Owing to their improved lipophilicity, prenylated natural products are proven to possess better binding affinity to target proteins and better bioavailability compared to nonprenylated derivatives, creating a direct impact on the biological activity [19,20]. Therefore, prenylated DKPs have demonstrated to be possible candidates for drug development and discovery [21,22]. In the current study, we report the isolation of different prenylated indole diketopiperazine alkaloids, including a new triprenylated derivative rubrumline P (1) and a rare tetraprenylated known congener 1Q2 (7), from a marine sediment-derived fungus, A. chevalieri, through a bioassay-guided fractionation. In addition, the crystal structure of a known derivative, rubrumline I (2), is reported for the first time. Genome sequencing of the fungus revealed secondary metabolite regions presumably involved in the synthesis of the reported prenylated metabolites. Furthermore, an analysis of the isolated compounds’ cytotoxic efficacy against pancreatic cancer cell line PANC-1 cells has been performed, followed by cell cycle analyses of the isolated compounds.

2. Results and Discussion

2.1. Bioactivity-Guided Fractionation of the Ethyl Acetate Extract of Aspergillus chevalieri

After cultivating A. chevalieri on a solid rice medium supplemented with 3.5% NaCl (mimicking the salinity of seawater), the crude ethyl acetate extract of the fungus was initially subjected to chromatographic separation via vacuum liquid chromatography. Subsequently, the produced VLC fractions were preliminary tested for their cytotoxic potential against the human pancreatic PANC-1 cancer cell line at a concentration of 100 µg/mL. Remarkable cytotoxic activity was observed for fractions 4 and 5 after 72 h compared to 1 µM of the microtubule inhibitor paclitaxel, part of the first-line treatment regimen for PDAC patients (Figure 1). Incubation of fraction 4 for 72 h reduced the viability of PANC-1 cells by about 99%. A comparable result was observed for fraction 5. Based on the bioassay result and HPLC profile of fraction 4 (100% EtOAc) compared to those of fraction 5 (90% DCM-MeOH), which was an oily fraction, fraction 4 was selected for further chromatographic separations to isolate and identify the active compounds.

2.2. Structure Elucidation

After our chromatographic fractionation of the crude extract of A. chevalieri on VLC, various separations were conducted on other stationary phases, followed by final purifications utilizing semi-preparative HPLC affording seven indole diketopiperazine alkaloids, compounds 1–7 (Figure 2), including one new alkaloid (1) in addition to six known mono-, di-, tri-, and tetraprenylated analogues identified as rubrumline I (2) [23], neoechinulin A (3) [24], neoechinulin D (4) [25], variecolorin G (5) [26], dehydroechinulin (6) [27], and 1Q2 (7) [8] through comparison of their 1D/2D NMR spectroscopic data with those in the literature.
Compound 1 was isolated as a beige-brown residue. Its molecular formula was determined to be C30H41N3O4 based on a positive HRESIMS analysis, indicating 12 degrees of unsaturation. The 1H-NMR data (Table 1) and HSQC analysis exhibited signals for two meta-coupled aromatic protons (δH 6.93, d, J = 1.5 Hz, H-4; and δH 6.74, d, J = 1.5 Hz, H-6), six singlet methyls at δH 1.51, 1.50, 1.28, 1.23, 1.72, and 1.71, assigned for H3-18, H3-19, H3-24, H3-25, H3-29, and H3-30, respectively, a doublet methyl (δH 1.60, d, J = 7.0, H3-20), one methoxy group (δH 3.28, 23-OCH3), and three protons of a vinyl group (δH 6.05, dd, J = 17.4, 10.5 Hz, H-16; δH 5.14, d, J = 10.5 Hz, H-17a; and δH 5.12, d, J = 17.4 Hz, H-17b). Moreover, proton signals for two methylenes (H-21 and H-26), four methines—including one aliphatic proton (δH 4.27, q, J = 6.9 Hz; H-12), two olefinic protons (δH 7.23, s, H-8; and δH 5.35, m, H-27), and one oxygenated proton (δH 3.80, d, J = 8.7 Hz, H-22)—and three NH protons (NH-1, NH-11, and NH-14) were also detected. The APT and HMBC spectroscopic data (Table 1) assigned the presence of 30 carbons, allocated for: seven methyl groups and one methoxy group (CH3-18, CH3-19, CH3-20, CH3-24, CH3-25, CH3-29, CH3-30, and 23-OCH3); three methylenes, including one olefinic (CH2-17) and two aliphatic (CH2-21, and CH2-26) groups; seven methines, with five olefinic/aromatic carbons (CH-4, CH-6, CH-8, CH-16, and CH-27), one oxygenated (CH-22), and one aliphatic (CH-12); and twelve quaternary carbons, accounting for two carbonyls (C-10, and C-13), eight olefinic/aromatic carbons (C-2, C-3, C-3a, C-5, C-7, C-7a, C-9, and C-28), one oxygenated (C-23), and one aliphatic carbon (C-15). Detailed inspection of the 1D and 2D NMR spectra of compound 1 revealed that compound 1 is an indole diketopiperazine derivative that is structurally similar to the known co-isolated rubrumline I (2), which was previously only characterized once from Eurotium rubrum F33, a marine sediment-derived fungus collected at a depth of 2067 m under the South Atlantic Ocean [23]. However, the signal for a methine group resonating at δH 7.06/δC 117.3 (CH-5) in rubrumline I was replaced by signals for an isoprenyl moiety in 1. This assignment was suggested from the molecular composition of 1 (C30H41N3O4), which, compared to rubrumline I (2) (C25H32N3O4), bears an additional isoprenyl group (-C5H9) constituting the last remaining degree of unsaturation. Moreover, this assignment was further deduced based on COSY correlations between H2-26 and H-27, together with the HMBC correlations from H2-26 to C-4 (δC 116.6), C-5 (δC 134.5), C-6 (δC 123.8), and C-28 (δC 132.0) and from H3-29/H3-30 to C-28, and C-27 (δC 124.3) (Figure 3A), together with the NOE correlations between H2-26 and H-4, and between H2-26 and H-6. The geometry of the double bond at C-8 was assigned to be Z based on the NOESY correlations between H-4 and NH-14 and between H-8 and CH3-18, together with the absence of cross peaks from H-8 to NH-14, which suggests the stable configuration of compound 1 (Figure 3B) that is also identical to the X-ray diffraction analysis structure of compound 2 (Figure 4). Moreover, the downfield shift of the olefinic proton H-8 (δH 7.23) implies a deshielding effect of the 10- carbonyl group, confirming the Z configuration of the double bond at C-8 [23,26,28]. Therefore, compound 1 was elucidated as a 5-prenyl analog of compound 2, representing a new rubrumline derivative, for which the trivial name rubrumline P is proposed.
The specific optical rotation of compound 1 is negative, which is consistent with the negative values reported for other known neoechinulin A series of indole diketopiperazine alkaloids with 12S and 22S configurations, proposing that the new compound 1 shares the same absolute configuration as the known derivatives [23,24,29]. Although the absolute configuration of the previously reported rubrumline derivatives was assigned using a modified Mosher’s method and CD measurement, no crystal structure has been reported so far for these derivatives [23]. Herein, we present an independent assignment of the absolute configuration of the known rubrumline I (2) via single-crystal X-ray diffraction analysis through anomalous dispersion for the first time, allowing an unambiguous assignment of the absolute configuration of 2 as 12S and 22S (Figure 4). Based on NMR data, optical rotations and biogenetic considerations, the same absolute configurations, as elucidated for compound 2 via X-ray diffraction analysis, can be assumed for the other alkaloids as well.

2.3. Genome Sequencing

The genome assembly of Aspergillus chevalieri resulted in a total length of 29,419,542 bp, with an N50 fragment length of 1,488,407 bp and an average coverage of 3960×. The assembly consists of 192 contigs, of which 8 contigs contain more than 1,000,000 base pairs (Table 2). These eight contigs correspond to the eight chromosomes of the fungal genome as represented in the reference strain in the NCBI database (NCBI RefSeq assembly: GCF_016861735.1) [30].
Regions coding for potential secondary metabolites were found on six of these eight contigs (Figure 5). Most were gene clusters for non-ribosomal peptide synthetases (NRPSs), which were found on five contigs, followed by regions for type I polyketide synthases (T1PKSs), terpenes, and fungal ribosomally synthesized and post-translationally modified peptide (RiPP)-like secondary metabolites, on two contigs each. Regions for NI-siderophones were also found on one contig. In an additional analysis with InterProScan, a potential region for terpenoid cyclases and protein prenyltransferases was also found on a 21,917 bp-long contig, which does not belong to the core genome.
Analysis of the gene clusters in the genome of A. chevalieri revealed the presence of gene regions for the production of non-ribosomal peptide synthetases, polyketide synthases, and terpenes. There is also an evidence that this fungus is able to synthesize prenyltransferases. Both findings indicate that A. chevalieri has the ability to synthesize isoprenylated natural products. The synthesis of isoprenylated natural products through the formation of echinulin prenyltransferase 1 (EchPT1) has so far only been described for other members of the genus Aspergillus (A. fumigatus, A. oryzae, and A. ruber), but not yet for Aspergillus chevalieri [8,31,32].

2.4. Cytotoxicity and Cell Cycle Analyses in the Pancreatic Ductal Adenocarcinoma Cell Line PANC-1

Based on the remarkable cytotoxicity results from the bioactivity-guided screening of the starting fraction 4, the purified compounds 1 and 4 were characterized in full dose–response curves in the selected pancreatic cancer cell line. The respective cytotoxic efficacy levels are displayed in Table 3.
In contrast to the standard-of-care treatment paclitaxel, for which IC50 values in the low nanomolar range are reported [33], compounds 1 and 4 display only moderate cytotoxic efficacy levels, with IC50 values of 25.8 and 23.4 µM, respectively.
To determine whether compound 1 or compound 4 affects the cell cycle of PANC-1 cells, a cell cycle analysis was performed. The tumor cells were treated with 30 µM of compound 1 or compound 4 for 24 h, respectively, and stained according to the Nicoletti method. Treatment with the spindle toxin paclitaxel served as a positive control. Treatment with compound 1 or compound 4 did not result in any significant changes in the cell cycle compared to the solvent control DMSO (Figure 6). However, a slight increase in the sub-G1 peak was observed after treatment with compounds 1 and 4, but this did not reach levels of statistical significance. In contrast, and as expected, treatment with 0.1 µM paclitaxel resulted in the arrest of the cell cycle in the G2 phase and a significant increase in the sub-G1 peak (Figure 6). Therefore, the cytotoxic effects of these compounds might be attributed to inducing apoptosis; however, the exact mechanism-of-action is still elusive.

3. Materials and Methods

3.1. General Compound Spectroscopic Analysis and Purification Procedures

Optical rotations were determined using a Jasco P-2000 polarimeter. The compounds were dissolved in optically pure solvents Uvasol® (spectroscopic-grade solvents, Merck, Darmstadt, Germany). The 1D and 2D NMR spectra were recorded in CDCl3 and MeOD using Bruker Avance III 500 or 600 MHz NMR spectrometers (Bruker BioSpin GmbH, Rheinstetten, Germany). Low-resolution mass spectra (ESI) were measured with an Ion-Trap-API Finnigan LCQ Deca (Thermo Quest, Egelsbach, Germany) mass spectrometer, while high-resolution mass spectrometry (HRESIMS) data were recorded on an FTHRMS-Orbitrap (Thermo-Finnigan, Egelsbach, Germany) mass spectrometer. HPLC analysis was conducted using a Dionex UltiMate-3400 SD with an LPG-3400SD pump coupled to a photodiode array detector (DAD3000RS), with routine detections at 235, 254, 280, and 340 nm. The separation column was a Knauer Eurospher C18 analytical column (125 × 4 mm i.d., 5 m), using the solvent gradient MeOH-(0.1% HCOOH in H2O), as follows: 0 min (10% MeOH); 5 min (10% MeOH); 35 min (100% MeOH); 45 min (100% MeOH). Purification of the compounds was performed using semipreparative HPLC on the VWR Hitachi Chromaster HPLC system (5160 pump; 5410 UV detector; Eurosphere-100 C18, 300 mm × 8 mm i.d., 10 m; Knauer, Germany) utilizing MeOH and H2O as eluting solvents, employing a flow rate of 5 mL/min. Column chromatography included various stationary phases such as Sephadex LH-20 (0.25–0.1 mm mesh size, Merck) and Merck MN silica gel 60 M (0.04–0.063 mm mesh size). TLC plates precoated with silica gel F254 (Merck) were used for monitoring fractions. Detection of spots on TLC was performed through UV absorption at 254 and 365 nm, or by spraying the plates with an anisaldehyde spray reagent followed by heating.

3.2. Fungal Material

The fungus Aspergillus chevalieri LH15-100R2 was isolated from a marine sediment, which was collected from the Red Sea in November 2017 at a depth of 15 m near to the lighthouse of Dahab, Egypt. The fungus was identified as A. chevalieri (GenBank accession no. OR605556) through amplification and sequencing of the internal transcribed spacer region (ITS), including the 5.8S ribosomal DNA, followed by a BLAST search in NCBI, as described before [34]. This fungal strain is stored at −80 °C in the Institute of Pharmaceutical Biology and Biotechnology, Heinrich Heine University, Düsseldorf.

3.3. Fermentation, Extraction, and Isolation

Fermentation of the fungus was carried out in ten 1L Erlenmeyer flasks, each containing 100 g of rice (Oryza Milchreis), 3.5 g of NaCl, and 110 mL of demineralized water. After autoclaving at 121 °C for 20 min then cooling to room temperature, the fungus was transferred to the solid rice medium. The fungal culture was left to grow under static conditions for 23 days at room temperature until the fungus had totally overgrown the medium. Afterwards, the solid fermented fungus was extracted two times with EtOAc (each with 600 mL). After soaking overnight in EtOAc, the solid medium was cut into small pieces and then shaken for 8 h at 150 rpm. The combined extracts were concentrated via evaporation of EtOAc under reduced pressure, yielding around 15 g of EtOAc crude extract. The crude extract (15 g) was fractionated through VLC (vacuum liquid chromatography) on silica gel as a stationary-phase with a gradient elution of solvents consisting of mixtures of n-hexane/EtOAc and CH2Cl2/MeOH, to afford seven fractions (A. ch Fr. 1–7). Fraction A. ch. Fr. 4 (640 mg), eluted with 100% EtOAc, was further purified via Sephadex LH20 column chromatography using CH2Cl2-MeOH (1:1) as a mobile phase, yielding three subfractions (A. ch Fr. 4.1–4.3). Subfraction (A. ch Fr. 4.2) (205.6 mg) was purified using semi-preparative HPLC with a gradient of MeOH-H2O containing 0.1% formic acid (65:35 to 95:05 in 21 min) to afford 1 (4.43 mg), 2 (1.04 mg), 3 (11.02 mg), 4 (40.48 mg), 5 (4.60 mg), 6 (3.01 mg), and 7 (1.47 mg) eluting at retention times; 33.5, 29.8, 25.7, 31.4, 32.0, 35.2, and 36.9 min, respectively
Rubrumline P (1): beige-brown residue; [α]20D-14.216 (c 0.10, CHCl3); UV (MeOH) λmax 371.0, 341.0 and 210.8 nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 508.3173 [M + H]+ (calcd for C30H42N3O4, 508.3170).

3.4. Crystallographic Analysis of Compound 2

Crystals were obtained through solvent evaporation (MeOH). The data collection process was as follows: Single crystals were measured on a Rigaku XtaLAB Synergy-S, Dualflex, HyPix diffractometer with a micro-focus X-ray tube, with Cu-Kα radiation (λ = 1.54182 Å) at 301.6(1) K. Cell refinement, data collection, and data reduction were performed with CrysalisPro [35]. The Structure solution was conducted using SHELXT 2014/4 [36]. Structure refinement was performed with SHELXL 2017/1 [37], and implemented in the Olex2 software (version 1.5) package [38]. All non-hydrogen atoms were refined with anisotropic displacement parameters. All hydrogen atoms on C were positioned geometrically (with C–H = 0.93 Å for aromatic and vinyl CH, 0.98 Å for aliphatic CH, 0.97 Å for CH2, and 0.96 Å for CH3) and refined using riding models (AFIX 43, 93, 13, 23, and 137 with Uiso(H) = 1.2 Ueq(C) (CH, CH2) and 1.5 Ueq(C) (CH3)). Protic hydrogen atoms on N and O were found and refined with Uiso(H) = 1.5 Ueq(N/O). The crystal structure was deposited into the Cambridge Crystallographic Data Center (CCDC no. 2308479).

3.5. DNA Isolation and Genome Sequencing

DNA isolation was performed according to the Quick DNA fungal/bacterial miniprep protocol provided by Zymo Research [39].
For long-read Nanopore sequencing, the NBE_9169_v114_revH_15Sep2022 protocol for ligation sequencing of genomic DNA was followed, using the SQK-NBD114 native barcoding kit and a PromethION Flow Cell R10 Version. Reads were assembled using Flye Version 2.9.2-b1794 [40] with asmCoverage-Mode. Antismash [41] and InterProScan Version 5.58-91.0 [42] were used to detect gene clusters and identify potential genes of interest.

3.6. Cell Culture and Cytotoxic Activity

The PDAC cell line PANC-1, purchased from the American Type Culture Collection (ATCC), was cultured in Dulbecco’s modified Eagle medium (DMEM) (#41965039, Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS) (#10270-106, Gibco, Grand Island, NY, USA), as well as 1% penicillin-streptomycin (#15140122, Gibco, Grand Island, NY, USA). Cells were incubated at 37 °C in a humidified atmosphere supplemented with 5% CO2. Cell viability was assessed using the PrestoBlue HS Cell Viability Assay (#P50201, InvitrogenTM, Waltham, MA, USA) in 96-well plates (cat. no. 655090, Greiner Bio-One, Frickenhausen, Germany) by seeding 5000 cells per well. Compounds were incubated for 72 h. Paclitaxel (#sc-201439, Santa Cruz Biotechnology, Heidelberg, Germany) dissolved in DMSO (#A994.1, Carl Roth, Karlsruhe, Germany) was used as a positive control. Fluorescence values were recorded using the Tecan SPARK instrument (Tecan Group, Männedorf, Switzerland), according to the manufacturer’s protocol.

3.7. Cell Cycle Analysis

For analysis of the cell cycles, 9 × 104 cells/mL of PANC-1 were cultured in 6-well plates (Greiner Bio-One). After treatment for 24 h and harvesting via trypsin, the cells were washed with D-PBS. For cell cycle analyses, the cells were suspended in 100 µL of hypotonic buffer (1% sodium citrate, 0.1% Triton X-100, and 50 µg/mL propidium iodide in double-distilled water). The suspension was incubated for 10 min at room temperature. Flow cytometry was performed with the BD FACSLyric flow cytometer (#87135, BD Biosciences, Heidelberg, Germany), whereby FlowJo software (version 10.8.1) was utilized for the analysis.

3.8. Statistical Analysis

GraphPad Prism version 8.4.3 (GraphPad Software, California, USA) was used to perform statistical analyses and graphical illustrations. Non-linear regression was performed to assess cell viability, obtaining IC50 values. To determine statistical significance, a one-way analysis of variance (ANOVA) was used, wherein a p-value below 0.05 was defined as statistically significant.

4. Conclusions

Following a bioassay-guided strategy for the isolation of presumable drugs or drug-led structures originating from a natural source for use against the human pancreatic adenocarcinoma cell line PANC-1, several indole diketopiperazine alkaloids, including a new triprenylated alkaloid, named rubrumline P (1), together with other known prenylated derivatives (2–7) were obtained from rice culture supplemented with 3.5% NaCl of the marine sediment-derived fungus, Aspergillus chevalieri. Two isolated indole DKPs, rubrumline P (1) and neoechinulin D (4), showed cytotoxic efficacy with IC50 values of 25.8 and 23.4 µM, respectively. In addition, a cell cycle analysis of the isolated secondary metabolites has been conducted. Most notably, our analysis of the fungal genome of A. chevalieri, which is described for the first time, revealed the ability of this fungus to synthesize prenyltransferases as tailoring enzymes involved in the production of prenylated compounds, as evidenced by the isolation of different prenylated indole DKPs from the fungus. This represents a starting point for the optimization of such prenylated alkaloids for future drug discoveries and development.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md22010005/s1, Figures S1–S10: The UV spectrum, HRESIMS, 1D and 2D NMR spectra of compound 1, and the packing diagram, determined via single-crystal x-ray diffraction, and hydrogen bond network of compound 2; Tables S1–S5: crystal data and refinement, fractional atomic coordinates, atomic displacement parameters, geometric parameters, and hydrogen bond geometry for compound 2.

Author Contributions

Investigation, D.H.E.-K., D.D.O., K.S., A.D., S.S., D.N., S.M., T.H.H.S. and H.W.; concept development, D.H.E.-K. and N.T.; resources, D.F., C.J, K.P. and N.T.; writing—original draft preparation, D.H.E.-K., K.S., A.D., S.S. and N.T.; writing—review and editing, C.J. and N.T. All authors have read and agreed to the published version of the manuscript.

Funding

This study received funding from Deutsche Forschungsgemeinschaft (DFG) under grant no. 440366605 (for the Rigaku diffractometer).

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The CCDC number 2308479 for compound 2 contains the supplementary crystallographic data reported in this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Center via www.ccdc.cam.ac.uk/data_request/cif (accessed on 16 November 2023).

Acknowledgments

We would like to express our deep gratitude to Peter Proksch for his careful and critical revision of the manuscript and for his valuable and constant support as a mentor and friend. We wish to thank Dent. Abdel Rahman O. El Mekkawi, EFR, PADI IDC staff instructor, founder of I Dive Tribe, Dahab, South Sinai, Egypt, for collecting the sediment sample.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Słodkowski, M.; Wroński, M.; Karkocha, D.; Kraj, L.; Śmigielska, K.; Jachnis, A. Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal Adenocarcinoma. Cancers 2023, 15, 2584. [Google Scholar] [CrossRef] [PubMed]
  2. Adamska, A.; Domenichini, A.; Falasca, M. Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies. Int. J. Mol. Sci. 2017, 18, 1338. [Google Scholar] [CrossRef] [PubMed]
  3. He, X.; Wang, N.; Zhang, Y.; Huang, X.; Wang, Y. The therapeutic potential of natural products for treating pancreatic cancer. Front. Pharmacol. 2022, 13, 1051952. [Google Scholar] [CrossRef] [PubMed]
  4. Zhang, Z.; Wang, J.; Liu, B.; Liu, Y.; Shi, X.; Li, W.; Xin, H.; Xin, J.; Hao, C. Anticancer effects of herbal medicines in pancreatic ductal adenocarcinoma through modulation of steroid hormone response proteins. Sci. Rep. 2022, 12, 9910. [Google Scholar] [CrossRef] [PubMed]
  5. Kim, A.; Ha, J.; Kim, J.; Cho, Y.; Ahn, J.; Cheon, C.; Kim, S.-H.; Ko, S.-G.; Kim, B. Natural Products for Pancreatic Cancer Treatment: From Traditional Medicine to Modern Drug Discovery. Nutrients 2021, 13, 3801. [Google Scholar] [CrossRef]
  6. Xie, B.; Hänsel, J.; Mundorf, V.; Betz, J.; Reimche, I.; Erkan, M.; Büdeyri, I.; Gesell, A.; Kerr, R.G.; Ariantari, N.P.; et al. Pseudopterosin and O-Methyltylophorinidine Suppress Cell Growth in a 3D Spheroid Co-Culture Model of Pancreatic Ductal Adenocarcinoma. Bioengineering 2020, 7, 57. [Google Scholar] [CrossRef] [PubMed]
  7. Wohlgemuth, V.; Kindinger, F.; Li, S.M. Convenient synthetic approach for tri- and tetraprenylated cyclodipeptides by consecutive enzymatic prenylations. Appl. Microbiol. Biotechnol. 2018, 102, 2671–2681. [Google Scholar] [CrossRef] [PubMed]
  8. Wohlgemuth, V.; Kindinger, F.; Xie, X.; Wang, B.G.; Li, S.M. Two Prenyltransferases Govern a Consecutive Prenylation Cascade in the Biosynthesis of Echinulin and Neoechinulin. Org. Lett. 2017, 19, 5928–5931. [Google Scholar] [CrossRef]
  9. Ma, Y.-M.; Liang, X.-A.; Kong, Y.; Jia, B. Structural Diversity and Biological Activities of Indole Diketopiperazine Alkaloids from Fungi. J. Agric. Food Chem. 2016, 64, 6659–6671. [Google Scholar] [CrossRef]
  10. Xu, W.; Gavia, D.J.; Tang, Y. Biosynthesis of fungal indole alkaloids. Nat. Prod. Rep. 2014, 31, 1474–1487. [Google Scholar] [CrossRef]
  11. Giessen, T.W.; Marahiel, M.A. Rational and combinatorial tailoring of bioactive cyclic dipeptides. Front. Microbiol. 2015, 6, 785. [Google Scholar] [CrossRef] [PubMed]
  12. Winkelblech, J.; Fan, A.; Li, S.-M. Prenyltransferases as key enzymes in primary and secondary metabolism. Appl. Microbiol. Biotechnol. 2015, 99, 7379–7397. [Google Scholar] [CrossRef] [PubMed]
  13. Li, S.-M. Applications of dimethylallyltryptophan synthases and other indole prenyltransferases for structural modification of natural products. Appl. Microbiol. Biotechnol. 2009, 84, 631–639. [Google Scholar] [CrossRef] [PubMed]
  14. Sharifi-Rad, J.; Bahukhandi, A.; Dhyani, P.; Sati, P.; Capanoglu, E.; Docea, A.O.; Al-Harrasi, A.; Dey, A.; Calina, D. Therapeutic Potential of Neoechinulins and Their Derivatives: An Overview of the Molecular Mechanisms Behind Pharmacological Activities. Front. Nutr. 2021, 8, 664197. [Google Scholar] [CrossRef] [PubMed]
  15. Gao, H.; Zhu, T.; Li, D.; Gu, Q.; Liu, W. Prenylated indole diketopiperazine alkaloids from a mangrove rhizosphere soil derived fungus Aspergillus effuses H1-1. Arch. Pharmacal Res. 2013, 36, 952–956. [Google Scholar] [CrossRef] [PubMed]
  16. Cai, S.; Sun, S.; Peng, J.; Kong, X.; Zhou, H.; Zhu, T.; Gu, Q.; Li, D. Okaramines S–U, three new indole diketopiperazine alkaloids from Aspergillus taichungensis ZHN-7-07. Tetrahedron 2015, 71, 3715–3719. [Google Scholar] [CrossRef]
  17. Akashi, S.; Kimura, T.; Takeuchi, T.; Kuramochi, K.; Kobayashi, S.; Sugawara, F.; Watanabe, N.; Arai, T. Neoechinulin a impedes the progression of rotenone-induced cytotoxicity in PC12 cells. Biol. Pharm. Bull. 2011, 34, 243–248. [Google Scholar] [CrossRef]
  18. Wijesekara, I.; Li, Y.-X.; Vo, T.-S.; Van Ta, Q.; Ngo, D.-H.; Kim, S.-K. Induction of apoptosis in human cervical carcinoma HeLa cells by neoechinulin A from marine-derived fungus Microsporum sp. Process Biochem. 2013, 48, 68–72. [Google Scholar] [CrossRef]
  19. Terao, J.; Mukai, R. Prenylation modulates the bioavailability and bioaccumulation of dietary flavonoids. Arch. Biochem. Biophys. 2014, 559, 12–16. [Google Scholar] [CrossRef]
  20. Botta, B.; Vitali, A.; Menendez, P.; Misiti, D.; Delle Monache, G. Prenylated flavonoids: Pharmacology and biotechnology. Curr. Med. Chem. 2005, 12, 717–739. [Google Scholar] [CrossRef]
  21. Liu, R.; Zhang, H.; Wu, W.; Li, H.; An, Z.; Zhou, F. C7-Prenylation of Tryptophan-Containing Cyclic Dipeptides by 7-Dimethylallyl Tryptophan Synthase Significantly Increases the Anticancer and Antimicrobial Activities. Molecules 2020, 25, 3676. [Google Scholar] [CrossRef] [PubMed]
  22. Li, S.-M. Prenylated indole derivatives from fungi: Structure diversity, biological activities, biosynthesis and chemoenzymatic synthesis. Nat. Prod. Rep. 2010, 27, 57–78. [Google Scholar] [CrossRef] [PubMed]
  23. Chen, X.; Si, L.; Liu, D.; Proksch, P.; Zhang, L.; Zhou, D.; Lin, W. Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin. Eur. J. Med. Chem. 2015, 93, 182–195. [Google Scholar] [CrossRef] [PubMed]
  24. Alhadrami, H.A.; Burgio, G.; Thissera, B.; Orfali, R.; Jiffri, S.E.; Yaseen, M.; Sayed, A.M.; Rateb, M.E. Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors. Mar. Drugs 2022, 20, 163. [Google Scholar] [CrossRef] [PubMed]
  25. Dossena, A.; Marchelli, R.; Pochini, A. Neoechinulin D, a new isoprenylated dehydrotryptophyl metabolite from Aspergillus amstelodami. Experientia 1975, 31, 1249. [Google Scholar] [CrossRef]
  26. Wang, W.-L.; Lu, Z.-Y.; Tao, H.-W.; Zhu, T.-J.; Fang, Y.-C.; Gu, Q.-Q.; Zhu, W.-M. Isoechinulin-type Alkaloids, Variecolorins A–L, from Halotolerant Aspergillus variecolor. J. Nat. Prod. 2007, 70, 1558–1564. [Google Scholar] [CrossRef] [PubMed]
  27. Li, D.-L.; Li, X.-M.; Li, T.-G.; Dang, H.-Y.; Wang, B.-G. Dioxopiperazine Alkaloids Produced by the Marine Mangrove Derived Endophytic Fungus Eurotium rubrum. Helv. Chim. Acta 2008, 91, 1888–1893. [Google Scholar] [CrossRef]
  28. Marchelli, R.; Dossena, A.; Pochini, A.; Dradi, E. The structures of five new didehydropeptides related to neoechinulin, isolated from Aspergillus amstelodami. J. Chem. Soc. Perkin Trans. 1977, 1, 713–717. [Google Scholar] [CrossRef]
  29. Meng, L.-H.; Du, F.-Y.; Li, X.-M.; Pedpradab, P.; Xu, G.-M.; Wang, B.-G. Rubrumazines A–C, Indolediketopiperazines of the Isoechinulin Class from Eurotium rubrum MA-150, a Fungus Obtained from Marine Mangrove-Derived Rhizospheric Soil. J. Nat. Prod. 2015, 78, 909–913. [Google Scholar] [CrossRef]
  30. Genome Assembly AchevalieriM1_assembly01. Available online: www.ncbi.nlm.nih.gov/datasets/genome/GCF_016861735.1 (accessed on 28 November 2023).
  31. Li, W.; Xie, X.; Liu, J.; Yu, H.; Li, S.M. Prenylation of dimeric cyclo-L-Trp-L-Trp by the promiscuous cyclo-L-Trp-L-Ala prenyltransferase EchPT1. Appl. Microbiol. Biotechnol. 2023, 107, 6887–6895. [Google Scholar] [CrossRef]
  32. Yu, X.; Li, S.-M. Chapter Thirteen—Prenyltransferases of the Dimethylallyltryptophan Synthase Superfamily. In Methods in Enzymology; Hopwood, D.A., Ed.; Academic Press: Cambridge, MA, USA, 2012; Volume 516, pp. 259–278. [Google Scholar]
  33. Brumskill, S.; Barrera, L.N.; Calcraft, P.; Phillips, C.; Costello, E. Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs. J. Physiol. Biochem. 2023, 79, 223–234. [Google Scholar] [CrossRef] [PubMed]
  34. Kjer, J.; Debbab, A.; Aly, A.H.; Proksch, P. Methods for isolation of marine-derived endophytic fungi and their bioactive secondary products. Nat. Protoc. 2010, 5, 479–490. [Google Scholar] [CrossRef] [PubMed]
  35. CrysAlisPRO, v171.42; Oxford Diffraction/Agilent Technologies UK Ltd.: Yarnton, UK, 2022.
  36. Sheldrick, G.M. SHELXT–Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  37. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  38. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  39. Matsumoto, Y.; Nagamachi, T.; Yoshikawa, A.; Yamada, T.; Sugita, T. A joint PCR-based gene-targeting method using electroporation in the pathogenic fungus Trichosporon asahii. AMB Express 2022, 12, 91. [Google Scholar] [CrossRef] [PubMed]
  40. Kolmogorov, M.; Bickhart, D.M.; Behsaz, B.; Gurevich, A.; Rayko, M.; Shin, S.B.; Kuhn, K.; Yuan, J.; Polevikov, E.; Smith, T.P.L.; et al. metaFlye: Scalable long-read metagenome assembly using repeat graphs. Nat. Methods 2020, 17, 1103–1110. [Google Scholar] [CrossRef]
  41. Blin, K.; Shaw, S.; Kloosterman, A.M.; Charlop-Powers, Z.; van Wezel, G.P.; Medema, M.H.; Weber, T. antiSMASH 6.0: Improving cluster detection and comparison capabilities. Nucleic Acids Res. 2021, 49, W29–W35. [Google Scholar] [CrossRef]
  42. Paysan-Lafosse, T.; Blum, M.; Chuguransky, S.; Grego, T.; Pinto, B.L.; Salazar, G.A.; Bileschi, M.L.; Bork, P.; Bridge, A.; Colwell, L.; et al. InterPro in 2022. Nucleic Acids Res. 2023, 51, D418–D427. [Google Scholar] [CrossRef]
Marinedrugs 22 00005 g001
Figure 1. Results of the bioassay-guided fractionation: Cytotoxic effects of the vacuum liquid chromatography (VLC) fractions of Aspergillus chevalieri on PANC-1 cells. Cells were seeded into a 96-well plate at a concentration of 5 × 103 cells/well and treated for 72 h after seeding with the different VLC fractions at a concentration of 100 μg/mL. A solvent control (1% DMSO) and a positive control (1 μM paclitaxel) were incubated for 72 h. Cell viability is expressed as the percentage of untreated cells. Error bars indicate standard errors of the mean (SEM) (n = 1 with three technical replicates per subjected fraction).
Figure 1. Results of the bioassay-guided fractionation: Cytotoxic effects of the vacuum liquid chromatography (VLC) fractions of Aspergillus chevalieri on PANC-1 cells. Cells were seeded into a 96-well plate at a concentration of 5 × 103 cells/well and treated for 72 h after seeding with the different VLC fractions at a concentration of 100 μg/mL. A solvent control (1% DMSO) and a positive control (1 μM paclitaxel) were incubated for 72 h. Cell viability is expressed as the percentage of untreated cells. Error bars indicate standard errors of the mean (SEM) (n = 1 with three technical replicates per subjected fraction).
Marinedrugs 22 00005 g001
Marinedrugs 22 00005 g002
Figure 2. Structures of the isolated compounds from Aspergillus chevalieri.
Figure 2. Structures of the isolated compounds from Aspergillus chevalieri.
Marinedrugs 22 00005 g002
Marinedrugs 22 00005 g003
Figure 3. (A) Key 1H-1H COSY and HMBC correlations of compound 1. (B) Key NOESY correlations of compound 1.
Figure 3. (A) Key 1H-1H COSY and HMBC correlations of compound 1. (B) Key NOESY correlations of compound 1.
Marinedrugs 22 00005 g003
Marinedrugs 22 00005 g004
Figure 4. Molecular structure of 2 from a single-crystal X-ray structure determination analysis (50% thermal ellipsoids, H atoms with arbitrary radii). See Figure S9 in the Supplementary Materials for the packing diagram and a diagram of the hydrogen-bonding network.
Figure 4. Molecular structure of 2 from a single-crystal X-ray structure determination analysis (50% thermal ellipsoids, H atoms with arbitrary radii). See Figure S9 in the Supplementary Materials for the packing diagram and a diagram of the hydrogen-bonding network.
Marinedrugs 22 00005 g004
Marinedrugs 22 00005 g005
Figure 5. Identified secondary metabolites regions for Aspergillus chevalieri. For each of the six genome assembly contigs on which regions for secondary metabolites were identified, the position of the region and the structure type of the metabolites encoded there are shown. In addition, the most similar metabolite cluster already known is indicated with the associated cluster type and the degree of similarity (%).
Figure 5. Identified secondary metabolites regions for Aspergillus chevalieri. For each of the six genome assembly contigs on which regions for secondary metabolites were identified, the position of the region and the structure type of the metabolites encoded there are shown. In addition, the most similar metabolite cluster already known is indicated with the associated cluster type and the degree of similarity (%).
Marinedrugs 22 00005 g005
Marinedrugs 22 00005 g006
Figure 6. Detection of cell cycle phases in PANC-1 cells. The cells were treated with 30 µM of compound 1, 30 µM of compound 4, or 0.1 µM paclitaxel for 24 h. Cell cycle analysis was performed according to the Nicoletti method. (a) Percentage of PANC-1 cells in the different cell cycles after 24 h of treatment with compound 1, compound 4, or paclitaxel, shown in explementary histograms. (b) Quantification of cell cycle phases. The cell cycles of at least 10,000 cells were analyzed via flow cytometry. Error bars indicate the standard errors of the mean (n = three independent experiments, with * = p ≤ 0.05, and **** = p ≤ 0.0001).
Figure 6. Detection of cell cycle phases in PANC-1 cells. The cells were treated with 30 µM of compound 1, 30 µM of compound 4, or 0.1 µM paclitaxel for 24 h. Cell cycle analysis was performed according to the Nicoletti method. (a) Percentage of PANC-1 cells in the different cell cycles after 24 h of treatment with compound 1, compound 4, or paclitaxel, shown in explementary histograms. (b) Quantification of cell cycle phases. The cell cycles of at least 10,000 cells were analyzed via flow cytometry. Error bars indicate the standard errors of the mean (n = three independent experiments, with * = p ≤ 0.05, and **** = p ≤ 0.0001).
Marinedrugs 22 00005 g006
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR spectroscopic data recorded in CDCl3 for compound 1 (δ in ppm).
Table 1. 1H (600 MHz) and 13C (150 MHz) NMR spectroscopic data recorded in CDCl3 for compound 1 (δ in ppm).
No.δC, TypeδH (Mult, J in Hz)HMBC (from H to C)
2144.7, C
3102.8, C
3a126.6, C
4116.6, CH6.93, d (1.5)3, 6, 7a, 21
5134.5, C
6123.8, CH6.74, d (1.5)4, 7a, 26
7123.5, C
7a132.9, C
8113.2, CH7.23, s2, 3a, 10
9124.0, C
10160.4, C
1251.8, CH4.27, q (6.9)10, 13, 20
13165.5, C
1539.4, C
16144.6, CH6.05, dd (17.4, 10.5)2, 15, 18, 19
17112.7, CH25.14, d (10.5)15, 16
5.12, d (17.4)
1827.6, CH31.51, s2, 15, 16, 19
1927.5, CH31.50, s2, 15, 16, 18
2021.1, CH31.60, d (6.9)12, 13
2136.3, CH22.85, d (15.0)7, 7a, 28
2.94, dd (15.0, 8.7)
2278.2, CH3.80, d (8.7)7, 26, 28, 29, 30
2377.8, C
2420.5, CH31.28, s 27, 28, 30
2518.5, CH31.23, s27, 28, 29
2634.6, CH23.38, m4, 5, 6, 22, 23
27124.3, CH5.35, m24, 25
28132.0, C
2925.9, CH31.72, s22, 23, 25
3018.0, CH31.71, s22, 23, 24
1-NH 10.21, s2, 3, 3a, 7a
11-NH 6.34, br s10, 13
14-NH 7.47, br s10, 12, 13
23-OCH349.4, OCH33.28, s28
Table 2. Length and coverage of the Aspergillus chevalieri genome contigs and the identified secondary metabolite regions.
Table 2. Length and coverage of the Aspergillus chevalieri genome contigs and the identified secondary metabolite regions.
Contig No.Length (bp)Coverage (x-Fold)Secondary Metabolite Regions
24,649,6514036NRPS-like; fungal-RiPP-like; terpene; NI-siderophore
1873,079,0014045T1PKS
1232,864,3954042NRPS; T1PKS
2601,732,8544039NRPS
711,589,1884047NRPS; fungal-RiPP-like; terpene
2841,488,4074039NRPS-like
3281,357,1484052no secondary metabolite region found
3151,177,9764057no secondary metabolite region found
14921,9173994Terpenoid cyclases/Protein prenyltransferases
Table 3. Cytotoxic efficacy in PANC-1 cells represented by the respective IC50 values after 72 h of incubation. The arithmetic means of three independent biological repeats and their respective standard deviations are depicted.
Table 3. Cytotoxic efficacy in PANC-1 cells represented by the respective IC50 values after 72 h of incubation. The arithmetic means of three independent biological repeats and their respective standard deviations are depicted.
CompoundIC50 (±SD) [µM]
PANC-1
125.8 ± 1.3
423.4 ± 1.8
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

El-Kashef, D.H.; Obidake, D.D.; Schiedlauske, K.; Deipenbrock, A.; Scharf, S.; Wang, H.; Naumann, D.; Friedrich, D.; Miljanovic, S.; Haj Hassani Sohi, T.; et al. Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus Aspergillus chevalieri against Pancreatic Ductal Adenocarcinoma. Mar. Drugs 2024, 22, 5. https://doi.org/10.3390/md22010005

AMA Style

El-Kashef DH, Obidake DD, Schiedlauske K, Deipenbrock A, Scharf S, Wang H, Naumann D, Friedrich D, Miljanovic S, Haj Hassani Sohi T, et al. Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus Aspergillus chevalieri against Pancreatic Ductal Adenocarcinoma. Marine Drugs. 2024; 22(1):5. https://doi.org/10.3390/md22010005

Chicago/Turabian Style

El-Kashef, Dina H., Deborah D. Obidake, Katja Schiedlauske, Alina Deipenbrock, Sebastian Scharf, Hao Wang, Daniela Naumann, Daniel Friedrich, Simone Miljanovic, Takin Haj Hassani Sohi, and et al. 2024. "Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus Aspergillus chevalieri against Pancreatic Ductal Adenocarcinoma" Marine Drugs 22, no. 1: 5. https://doi.org/10.3390/md22010005

APA Style

El-Kashef, D. H., Obidake, D. D., Schiedlauske, K., Deipenbrock, A., Scharf, S., Wang, H., Naumann, D., Friedrich, D., Miljanovic, S., Haj Hassani Sohi, T., Janiak, C., Pfeffer, K., & Teusch, N. (2024). Indole Diketopiperazine Alkaloids from the Marine Sediment-Derived Fungus Aspergillus chevalieri against Pancreatic Ductal Adenocarcinoma. Marine Drugs, 22(1), 5. https://doi.org/10.3390/md22010005

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop